V
Vincent Cottin
Researcher at Claude Bernard University Lyon 1
Publications - 675
Citations - 29630
Vincent Cottin is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 68, co-authored 574 publications receiving 21594 citations. Previous affiliations of Vincent Cottin include University of Lyon & Institut national de la recherche agronomique.
Papers
More filters
Journal ArticleDOI
Étude exploratoire évaluant l’efficacité et la tolérance d’évérolimus chez des patientes atteintes de lymphangioléiomyomatose
Vincent Cottin,Sergio Harari,H J Goldberg,Sanjeev Khindri,L Henske,Shibadas Biswal,S Koehne-Voss,John M. Kovarik,S Ma,F X Mc Cormack +9 more
Proceedings ArticleDOI
Unclassifiable interstitial lung disease: a distinct entity with heterogeneous progression
TL;DR: In this article, the authors evaluated the disease course in patients with interstitial lung disease (uILD) and explored predictors of disease progression, defined as > 10% decline in absolute forced vital capacity (FVC) or > 5% FVC decline with evidence of disease progress on HRCT within 1 year of follow-up.
Journal ArticleDOI
Reply: The ATS/JRS Guidelines on Lymphangioleiomyomatosis: Filling in the Gaps
Francis X. McCormack,Nishant Gupta,Geraldine R. Finlay,Lisa R. Young,Simon R. Johnson,Vincent Cottin,Kevin C. Wilson,Joel Moss +7 more
TL;DR: Although the current guidelines were focused on the decision to begin therapy with sirolimus, in future versions it is hoped to have sufficient data available to provide evidence-based recommendations for stopping the drug based on conversion to menopausal status, adverse events, lack of responsiveness to the drug or waning drug effect, or other reasons.
Journal Article
Characteristics Of Severe Pulmonary Hypertension Associated With COPD In A French Multicenter Study
Gaëlle Dauriat,A. Kanagaratnam,O. Sitbon,B. Lamia,Vincent Cottin,Matthieu Canuet,Martine Reynaud-Gaubert,Arnaud Bourdin,Emmanuel Bergot,C. Viacroze,Ari Chaouat,Christophe Pison,Y. Costa,Gabriel Thabut,Hervé Mal +14 more
Journal ArticleDOI
Clinical impact of TERT somatic mutation in telomerase-related gene mutation carriers after lung transplantation.
Ibrahima Ba,Caroline Kannengiesser,Hervé Mal,Martine Reynaud-Gaubert,Vincent Cottin,S. Hirsch,Clément Picard,Raphael Borie +7 more
TL;DR: In this paper , acquired TERT promoter mutations may counterbalanced the germline defect and reduce the risk of hematological complications in this population, and the presence of an acquired mutation was associated with reduced hematologic complications after transplantation and with better outcome in telomere-related gene mutation carriers.